The total transaction amounted to $87,500. Post-transaction, Mr. Valentine owned 74,785 shares valued at around $4.6 million. At the end of July, the company reported $190.7 million for the second quarter, up from the consensus estimate of $177.5 million.
Brean Capital upgraded NuVasive shares from “hold” to “buy” on Sept. 30. The company’s stock opened at $35.29 today with a market cap at $1.68 billion. The 52-week high is $39.89 and low is $24.05.
More articles on orthopedic devices:
Nevro files IPO—6 things to know
Amedica appoints Eric Stookey to board of directors
PODs under attack—5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
